Sánchez-Briales, P., Marques Vidas, M., López-Sánchez, P., López-Illázquez, M. V., Martín-Testillano, L., Vedat-Ali, A., & Portolés, J. (2024). The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus. Journal of Clinical Medicine, 13(5), 1360. https://doi.org/10.3390/jcm13051360
Chicago Style (17th ed.) CitationSánchez-Briales, Paula, María Marques Vidas, Paula López-Sánchez, María Victoria López-Illázquez, Lucía Martín-Testillano, Aylin Vedat-Ali, and Jose Portolés. "The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus." Journal of Clinical Medicine 13, no. 5 (2024): 1360. https://doi.org/10.3390/jcm13051360.
MLA (9th ed.) CitationSánchez-Briales, Paula, et al. "The Uricosuric Effect of SGLT2 Inhibitors Is Maintained in the Long Term in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus." Journal of Clinical Medicine, vol. 13, no. 5, 2024, p. 1360, https://doi.org/10.3390/jcm13051360.